Free Trial

Edesa Biotech (EDSA) Competitors

Edesa Biotech logo
$2.05 -0.01 (-0.49%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.06 +0.01 (+0.24%)
As of 07/8/2025 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EDSA vs. VTGN, ANL, ZIVO, GNTA, SNTI, CUE, PMVP, CNTB, MGX, and IFRX

Should you be buying Edesa Biotech stock or one of its competitors? The main competitors of Edesa Biotech include VistaGen Therapeutics (VTGN), Adlai Nortye (ANL), ZIVO Bioscience (ZIVO), Genenta Science (GNTA), Senti Biosciences (SNTI), Cue Biopharma (CUE), PMV Pharmaceuticals (PMVP), Connect Biopharma (CNTB), Metagenomi (MGX), and InflaRx (IFRX). These companies are all part of the "pharmaceutical products" industry.

Edesa Biotech vs. Its Competitors

VistaGen Therapeutics (NASDAQ:VTGN) and Edesa Biotech (NASDAQ:EDSA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

Edesa Biotech has a net margin of 0.00% compared to VistaGen Therapeutics' net margin of -6,777.08%. VistaGen Therapeutics' return on equity of -58.88% beat Edesa Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
VistaGen Therapeutics-6,777.08% -58.88% -52.38%
Edesa Biotech N/A -187.01%-78.72%

Edesa Biotech has a consensus price target of $5.00, suggesting a potential upside of 143.90%. Given Edesa Biotech's stronger consensus rating and higher possible upside, analysts plainly believe Edesa Biotech is more favorable than VistaGen Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
VistaGen Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Edesa Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

VistaGen Therapeutics has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500. Comparatively, Edesa Biotech has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500.

In the previous week, VistaGen Therapeutics and VistaGen Therapeutics both had 1 articles in the media. Edesa Biotech's average media sentiment score of 0.67 beat VistaGen Therapeutics' score of 0.00 indicating that Edesa Biotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
VistaGen Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Edesa Biotech
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

78.4% of VistaGen Therapeutics shares are held by institutional investors. Comparatively, 5.5% of Edesa Biotech shares are held by institutional investors. 1.3% of VistaGen Therapeutics shares are held by company insiders. Comparatively, 22.6% of Edesa Biotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Edesa Biotech has lower revenue, but higher earnings than VistaGen Therapeutics. VistaGen Therapeutics is trading at a lower price-to-earnings ratio than Edesa Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VistaGen Therapeutics$490K146.40-$51.42M-$1.66-1.48
Edesa BiotechN/AN/A-$6.17M-$1.59-1.29

Summary

Edesa Biotech beats VistaGen Therapeutics on 9 of the 15 factors compared between the two stocks.

Get Edesa Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDSA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EDSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDSA vs. The Competition

MetricEdesa BiotechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$14.47M$2.87B$5.47B$8.95B
Dividend YieldN/A2.46%5.25%4.06%
P/E Ratio-1.2920.8027.0020.10
Price / SalesN/A286.27428.95120.24
Price / CashN/A41.1936.8257.86
Price / Book3.367.487.985.56
Net Income-$6.17M-$55.04M$3.16B$248.40M
7 Day Performance0.49%2.44%2.39%4.67%
1 Month Performance4.59%1.90%2.18%6.64%
1 Year Performance-51.99%4.35%33.82%21.31%

Edesa Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDSA
Edesa Biotech
1.6697 of 5 stars
$2.05
-0.5%
$5.00
+143.9%
-51.8%$14.47MN/A-1.2920News Coverage
VTGN
VistaGen Therapeutics
1.125 of 5 stars
$2.00
+1.5%
N/A-27.4%$57.44M$490K-1.2040
ANL
Adlai Nortye
1.8108 of 5 stars
$1.47
-5.2%
$9.00
+512.2%
-52.3%$57.20M$5M0.00127Gap Up
ZIVO
ZIVO Bioscience
N/A$14.91
flat
N/A+85.9%$56.85M$15.85K-3.0610Gap Up
GNTA
Genenta Science
1.8622 of 5 stars
$3.05
-1.6%
$25.00
+719.7%
+19.2%$56.70MN/A0.007Positive News
Gap Up
SNTI
Senti Biosciences
2.092 of 5 stars
$2.11
-2.3%
$8.50
+302.8%
-32.7%$56.33M$2.56M-0.194
CUE
Cue Biopharma
4.073 of 5 stars
$0.68
-7.9%
$3.00
+339.7%
-25.0%$55.83M$7.99M-1.0260
PMVP
PMV Pharmaceuticals
3.0469 of 5 stars
$1.06
-0.9%
$5.50
+418.9%
-11.4%$55.59MN/A-0.9050
CNTB
Connect Biopharma
3.3141 of 5 stars
$0.98
-2.0%
$7.00
+614.3%
-12.7%$55.56M$26.03M0.00110News Coverage
High Trading Volume
MGX
Metagenomi
2.28 of 5 stars
$1.48
+1.4%
$13.00
+778.4%
-56.5%$54.58M$52.29M-0.70236Positive News
Gap Up
IFRX
InflaRx
2.6813 of 5 stars
$0.79
-2.2%
$6.60
+735.4%
-44.2%$54.23M$180K-0.9660

Related Companies and Tools


This page (NASDAQ:EDSA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners